Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Option Award | 2024-02-02 8:13 pm | N/A N/A | ZEVRA THERAPEUTICS INC. | ZVRA | Guenther Sven Chief Scientific Officer | 79,000 | $0 | 79,000 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 9:50 pm | N/A 2033-01-08 | KEMPHARM INC | KMPH | Guenther Sven Chief Scientific Officer | 306,000 | $0 | 306,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 5:17 pm | N/A 2032-01-31 | KEMPHARM INC | KMPH | Guenther Sven EVP, Research & Development | 83,486 | $0 | 83,486 (Direct) | View |
| 2021-08-20 Option Award | 2021-08-24 4:26 pm | N/A 2031-08-19 | KEMPHARM INC | KMPH | Guenther Sven EVP, Research & Development | 81,716 | $0 | 81,716 (Direct) | View |
| 2020-02-05 Option Award | 2020-02-07 9:39 pm | N/A 2030-02-04 | KEMPHARM INC | KMPH | Guenther Sven EVP, Research & Development | 160,000 | $0 | 160,000 (Direct) | View |
| 2019-11-25 Option Award | 2019-11-27 4:15 pm | N/A 2029-11-24 | KEMPHARM INC | KMPH | Guenther Sven EVP, Research & Development | 56,000 | $0 | 56,000 (Direct) | View |